Virus Res 2008, 135:267–272.CrossRef 26. Lindenbach BD, Rice MC: Flaviviridae: the viruses and their replication. In Fields virology. 4th edition. Edited by: Knipe DM, Howley PM. Lippincott-Williams and Wilkins. New York; 2001:991–1041. 27. Wilson JR, de Sessions P, Leon MA, Scholle F: West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction. J Virol 2008, 82:8262–8271.LY3023414 solubility dmso PubMedCrossRef 28. Chung K, Nybakken GE, Thompson BS, Engle MJ, Marri A, Fremont DH, Diamond this website MS: Antibodies
against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fcγ Receptor-Dependent and-Independent Mechanisms. J Virol 2006, 80:1340–1351.PubMedCrossRef 29. Volpina OM, Volkova TD, Koroev DO, Ivanov VT, Ozherelkov SV, Khoretonenko MV, Vorovitch MF, Stephenson JR, Timofeev AV: A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induced a protective immune response against fatal encephalitis in an experimental animal Autophagy screening model. Virus Res 2005, 112:95–99.PubMedCrossRef 30. Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, Chen JL, Huang YL,
Chen SS, Chiang HY: DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 1998, 72:191–200.PubMed 31. Xu G, Xu X, Li Z, He Q, Wu B, Sun S, Chen H: Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14–14–2) virus and its safety and immunogenicity. Vaccine 2004, 22:1846–1853.PubMedCrossRef 32. Lin C-W, Liu K-T, Huang H-D, Chen W-J: Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 2008, 30:205–214.PubMedCrossRef 33. Amorima J, Porchiaa BFMM, Balanb A, Cavalcantea RCM, da Costac S, de Barcelos Alvesc A, de Souza
Ferreiraa L: Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein. J Virol Methods 2010, 167:186–192.CrossRef 34. Sukupolvi-Petty S, Austin KS, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS: Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2. J Virol 2010, 84:9227–9239.PubMedCrossRef Loperamide 35. Shen X, Parks RJ, Montefiori DC, Kirchherr JL, Keele BF, Decker JM, Blattner WA, Gao F, Weinhold KJ, Hicks CB, Greenberg ML, Hahn BH, Shaw GM, Haynes BF, Tomaras GD: In Vivo gp41 Antibodies Targeting the 2F5 mAb Epitope Mediate HIV-1 Neutralization Breadth. J Virol 2009, 83:3617–3625.PubMedCrossRef 36. Denisova GF, Denisov DA, Yeung J, Loeb MB, Diamond MS, Bramson JL: A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: A case study using monoclonal antibodies against the West Nile virus E protein. Mol Immunol 2008, 46:125–134.PubMedCrossRef 37.